Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

3 Feb 2009 07:00

RNS Number : 6484M
Creston PLC
03 February 2009
Β 

ο»Ώ

3Β FebruaryΒ 2009

Creston plcΒ 

Interim Management StatementΒ 

Creston plcΒ (LSE: CRE), the Insight and Communications Group, announcesΒ its interim management statement for the period 1Β AprilΒ 2008Β toΒ 2 FebruaryΒ 2009.

Financial Performance Indicators

Trading for the nine months ending December 2008Β have been in line withΒ theΒ Board's expectations and demonstrate growth during a difficult economic environment:

RevenueΒ growthΒ of 4%

HeadlineΒ operating profitΒ marginΒ after head office costsΒ of 18% (2008: 18%)Β 

Operating cash conversion from EBITDA of 97 percent.Β 

Headline performance measures exclude the impact ofΒ theΒ non-recurringΒ chargesΒ outlined in the Company's Interim statement.

New Business

In the Interim statement for the six months ending September 2008, the GroupΒ announcedΒ net new business revenue annualised at Β£11m (2008: Β£5m). This excellent new business performance has continued to date with further wins across both Divisions, which include Boehringer Ingelheim, COI (Stroke Awareness), Unilever (Lynx), Services at Home, SpicersΒ and Xchanging. As the new calendar year starts, there continues to be aΒ goodΒ pipe line of new business opportunities across the GroupΒ and recent wins that will be announced shortly.

Operational Trading

The Board's business objectives remain unchanged with a focus on reducing debt and maintaining upper quartile key performance indicators (KPIs), such asΒ revenue per head,Β operating profit marginΒ and cash conversion.Β As noted above the cash conversion onΒ EBITDAΒ for the nine monthsΒ has been goodΒ and the reduction in net debt remains in line withΒ the Board's expectations.

As reported in the Group's Interim statement, only 21Β per centΒ of the Group's revenue is in advertising and over 70Β per centΒ in direct and digital marketing, healthcare marketing and market research. This diversification towards more resilient areas of the marketing industry has benefited the Group as demonstrated in the financial performance noted above.

The Communications Division has benefited from its weighting towards direct and digital marketing and offering integrated on and off line communication. This Division continues to achieve strong year on year growthΒ driven by an excellent new business performance.

Trading for the Insight Division continues to be robust in the larger companies ICM and Marketing Sciences. However,Β as reported in the Interims the niche discipline of qualitative market research continues to experience aΒ year-on-year declineΒ and the Company has taken the necessary steps to align costs and structure to the trading outlook.

Outlook

The Board is realistic about the tough trading environment theΒ UKΒ economy faces and as the Group prepares for the new financial year, it will reduce its operating cost baseΒ where necessary, so its KPIs remain in line.Β Based on the nine month trading performance to the end of December 2008, the Group remains on course to meet the Board's expectationsΒ for the current financial year.Β 

For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

BarrieΒ Brien, COO/CFO

www.creston.comΒ 

Hogarth Partnership Limited

020 7357 9477

Chris Matthews/Anthony Arthur/Β Fiona Noblet

Β 

About Creston plc

Creston is an Insight and Communications marketing services group. The Board's aim is to identify synergistic benefits between its marketing services companies offering premium services such as market research, direct and interactive marketing, advertising, public relations, insight;Β and to build a Group that offersΒ effective and accountableΒ marketingΒ solutionsΒ across both on-line and off-line channels.Β 

Creston's companies boast a range of blue-chip clients including the Amazon, AstraZeneca,Β Bayer, BMW, BT, Burger King,Β Canon, COI Communications, Cow & Gate,Β Daily Mirror,Β Diageo, eBay,Β First Direct,Β General Motors,Β GlaxoSmithKline,Β Halifax,Β Homeform,Β House of Fraser,Β Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons,Β NHS Lottery,Β Nissan, Norwich Union, Pfizer, RocheΒ Diagnostics,Β Royal Mail,Β SAB Miller,Β Sainsbury's, Tesco,Β Thorpe Park,Β Toshiba,Β Trinity Mirror,Β T-Mobile, Tropicana, Unilever, Vodafone, Walkers and WHΒ Smith.

Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSEALAAELXNEFE
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.